Sempra insider plans Rule 144 sale of 30,000 common shares

Sempra insider files notice to sell common stock under Rule 144.

Rhea-AI Filing Summary

Sempra insider files notice to sell common stock under Rule 144. The filing covers a proposed sale of 30,000 shares of Sempra common stock through Oppenheimer & Co. on the NYSE, with an indicated aggregate market value of $2,648,700. These shares were acquired on 02/19/2025 through the vesting of restricted stock units granted under Sempra's Long-Term Incentive Plan as equity compensation. The filing notes that the person signing the notice represents they are not aware of undisclosed material adverse information about Sempra's current or prospective operations.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Sempra's (SRE) latest Form 144 filing disclose?

The Form 144 notice discloses a proposed sale of 30,000 shares of Sempra common stock on the NYSE, with an aggregate market value of $2,648,700, to be executed through Oppenheimer & Co.

How many Sempra (SRE) shares are covered by this planned Rule 144 sale?

The notice covers 30,000 shares of Sempra common stock that are proposed to be sold.

When and how were the Sempra (SRE) shares in this Form 144 acquired?

The 30,000 shares were acquired on 02/19/2025 through the vesting of a grant of restricted stock units under Sempra's Long-Term Incentive Plan as an equity compensation award.

What is the approximate sale date and exchange for the Sempra (SRE) Form 144 shares?

The filing lists an approximate sale date of 01/02/2026, with the shares to be sold on the NYSE.

What market value and shares outstanding figures are noted for Sempra (SRE) in this filing?

The filing shows an aggregate market value of $2,648,700 for the 30,000 shares to be sold and states that 652,681,521 shares of Sempra common stock were outstanding.

What representation does the seller make in Sempra's (SRE) Form 144?

The person for whose account the securities are to be sold represents that they do not know any material adverse information about Sempra's current or prospective operations that has not been publicly disclosed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 01/02/2026 - 05:11 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001461446
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	SEMPRA
SEC File Number	001-14201
Address of Issuer	488 8TH AVENUE SAN DIEGO CALIFORNIA 92101
Phone	6196962000
Name of Person for Whose Account the Securities are To Be Sold	Martin Jeffrey W
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Oppenheimer & Co., Inc. 10880 Wilshire Boulevard Los Angeles CA 90024	30000	2648700.00	652681521	01/02/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	02/19/2025	Vesting of grant of restricted stock units under Sempra's Long-Term Incentive Plan	Sempra			30000	02/19/2025	Vesting of equity award received as compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks	The shares of common stock reflected in this Form 144 are sold in accordance with a written instruction and plan for trading securities established by Mr. Martin on August 11, 2025 pursuant to Rule 10b5-1(c) under the Securities Exchange Act of 1934.
Date of Notice	01/02/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	08/11/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	JEFFREY W. MARTIN BY: Lisa H. Abbot, Managing Attorney - Corporate and Securities of Sempra and Attorney-In-Fact
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)